Next Article in Journal
Indocyanine Green-Camptothecin Co-Loaded Perfluorocarbon Double-Layer Nanocomposite: A Versatile Nanotheranostics for Photochemotherapy and FDOT Diagnosis of Breast Cancer
Next Article in Special Issue
Developing Actively Targeted Nanoparticles to Fight Cancer: Focus on Italian Research
Previous Article in Journal
Synthetic Antiferromagnetic Gold Nanoparticles as Bimodal Contrast Agents in MRI and CT—An Experimental In Vitro and In Vivo Study
Previous Article in Special Issue
Biomaterials for Soft Tissue Repair and Regeneration: A Focus on Italian Research in the Field

Microfluidic Technology for the Production of Hybrid Nanomedicines

Nanotech Lab, Te. Far.T.I., Department Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy
Clinical and Experimental Medicine Ph.D. Program, University of Modena and Reggio Emilia, 41125 Modena, Italy
Department of Chemical and Biological Engineering, Princeton University, Princeton, NJ 08544, USA
Author to whom correspondence should be addressed.
Academic Editors: Dimitrios A. Lamprou and Duncan Craig
Pharmaceutics 2021, 13(9), 1495;
Received: 5 August 2021 / Revised: 6 September 2021 / Accepted: 13 September 2021 / Published: 17 September 2021
(This article belongs to the Special Issue Pharmaceutics and Drug Delivery in Italy)
Microfluidic technologies have recently been applied as innovative methods for the production of a variety of nanomedicines (NMeds), demonstrating their potential on a global scale. The capacity to precisely control variables, such as the flow rate ratio, temperature, total flow rate, etc., allows for greater tunability of the NMed systems that are more standardized and automated than the ones obtained by well-known benchtop protocols. However, it is a crucial aspect to be able to obtain NMeds with the same characteristics of the previously optimized ones. In this study, we focused on the transfer of a production protocol for hybrid NMeds (H-NMeds) consisting of PLGA, Cholesterol, and Pluronic® F68 from a benchtop nanoprecipitation method to a microfluidic device. For this aim, we modified parameters such as the flow rate ratio, the concentration of core materials in the organic phase, and the ratio between PLGA and Cholesterol in the feeding organic phase. Outputs analysed were the chemico–physical properties, such as size, PDI, and surface charge, the composition in terms of %Cholesterol and residual %Pluronic® F68, their stability to lyophilization, and the morphology via atomic force and electron microscopy. On the basis of the results, even if microfluidic technology is one of the unique procedures to obtain industrial production of NMeds, we demonstrated that the translation from a benchtop method to a microfluidic one is not a simple transfer of already established parameters, with several variables to be taken into account and to be optimized. View Full-Text
Keywords: nanomedicine; hybrid nanoparticles; nanoprecipitation; microfluidics nanomedicine; hybrid nanoparticles; nanoprecipitation; microfluidics
Show Figures

Figure 1

MDPI and ACS Style

Ottonelli, I.; Duskey, J.T.; Rinaldi, A.; Grazioli, M.V.; Parmeggiani, I.; Vandelli, M.A.; Wang, L.Z.; Prud’homme, R.K.; Tosi, G.; Ruozi, B. Microfluidic Technology for the Production of Hybrid Nanomedicines. Pharmaceutics 2021, 13, 1495.

AMA Style

Ottonelli I, Duskey JT, Rinaldi A, Grazioli MV, Parmeggiani I, Vandelli MA, Wang LZ, Prud’homme RK, Tosi G, Ruozi B. Microfluidic Technology for the Production of Hybrid Nanomedicines. Pharmaceutics. 2021; 13(9):1495.

Chicago/Turabian Style

Ottonelli, Ilaria, Jason Thomas Duskey, Arianna Rinaldi, Maria Vittoria Grazioli, Irene Parmeggiani, Maria Angela Vandelli, Leon Z. Wang, Robert K. Prud’homme, Giovanni Tosi, and Barbara Ruozi. 2021. "Microfluidic Technology for the Production of Hybrid Nanomedicines" Pharmaceutics 13, no. 9: 1495.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop